Biocytogen provides comprehensive, one-stop solutions for next-generation drug development, supporting the global biomedical community from target identification to IND application. Leveraging cutting-edge gene-editing technology and advanced pharmacological capabilities, Biocytogen offers a diverse portfolio of oncology-focused products and services.

In Vivo Models for Oncology Research

• Syngeneic models
• Xenograft models
• Human immune system reconstitution models
• Orthotopic models

Solutions for Various Therapeutic Modalities

• Monoclonal antibody
• Bispecific antibody
• Antibody drug conjugate (ADC)
• Cell therapy
• Small Molecule
• Tumor vaccine

Ex Vivo/In Vitro Platforms for Oncology Research

• PK/PD services
• In vitro pharmacology services
• Pathology platforms